Posts With Tag Cybersecurity in Biotech

Explore ORIC Pharmaceuticals' 2024 financial report detailing net losses, cash management, and R&D focus. A must-read for investors assessing future growth potential.

Explore Aptevo Therapeutics Inc.'s Q4 2024 financial report highlighting a net loss of $24.13M, declining cash reserves, and strategic partnerships amid operational challenges.